Elevance Health, Inc. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Elevance Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Elevance Health, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $1.41B, a 19.8% decline year-over-year.
  • Elevance Health, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $8.47B, a 0.01% decline year-over-year.
  • Elevance Health, Inc. annual Operating Income (Loss) for 2023 was $8.5B, a 2.61% increase from 2022.
  • Elevance Health, Inc. annual Operating Income (Loss) for 2022 was $8.28B, a 9.58% increase from 2021.
  • Elevance Health, Inc. annual Operating Income (Loss) for 2021 was $7.56B, a 18.9% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.47B $1.41B -$348M -19.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $8.82B $2.77B +$137M +5.21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $8.68B $3.02B +$185M +6.54% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $8.5B $1.28B +$25M +1.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $8.47B $1.76B -$495M -22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-17
Q2 2023 $8.97B $2.63B +$282M +12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-17
Q1 2023 $8.69B $2.83B +$404M +16.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q4 2022 $8.28B $1.26B +$1M +0.08% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $8.28B $2.25B +$192M +9.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $8.09B $2.35B +$265M +12.7% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-09-29
Q1 2022 $7.83B $2.43B +$266M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q4 2021 $7.56B $1.26B +$653M +108% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $6.91B $2.06B +$1.86B +924% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-19
Q2 2021 $5.05B $2.08B -$1.28B -38.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $6.33B $2.16B -$33M -1.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q4 2020 $6.36B $605M -$493M -44.9% Oct 1, 2020 Dec 31, 2020 10-Q 2023-10-18
Q3 2020 $6.85B $201M -$1.33B -86.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $8.18B $3.36B +$1.93B +134% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-21
Q1 2020 $6.25B $2.19B +$254M +13.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q4 2019 $6B $1.1B +$348M +46.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $5.65B $1.53B +$279M +22.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $5.37B $1.43B -$126M -8.08% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $5.5B $1.94B +$72M +3.85% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $5.43B $750M +$369M +97.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $5.06B $1.25B +$267M +27.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-23
Q2 2018 $4.79B $1.56B +$332M +27.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $4.46B $1.87B +$283M +17.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $4.18B $381M -$272M -41.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $4.45B $982M -$96.1M -8.91% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $4.54B $1.23B -$273M -18.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-25
Q1 2017 $4.82B $1.59B +$15M +0.96% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $4.8B $652M +$213M +48.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 $4.59B $1.08B -$144M -11.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $4.73B $1.5B -$11.9M -0.79% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $4.74B $1.57B -$8.9M -0.56% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $4.75B $440M -$446M -50.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $5.2B $1.22B +$30.6M +2.57% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $5.17B $1.51B +$289M +23.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-27
Q1 2015 $4.88B $1.58B +$461M +41.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $4.42B $886M +$466M +111% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $3.95B $1.19B +$190M +19% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $3.76B $1.22B -$800K -0.07% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $3.76B $1.12B -$239M -17.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $4B $419M +$7.6M +1.85% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $3.99B $1B -$2.8M -0.28% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $4B $1.22B +$232M +23.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-30
Q1 2013 $3.76B $1.36B +$145M +11.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $3.62B $412M -$101M -19.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $3.72B $1B +$31.2M +3.21% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $3.69B $992M +$45M +4.75% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-24
Q1 2012 $3.64B $1.21B -$138M -10.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q4 2011 $3.78B $513M -$181M -26.1% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $3.96B $973M -$67.1M -6.45% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $4.03B $947M -$111M -10.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $4.14B $1.35B +$63.6M +4.94% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q4 2010 $4.08B $693M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-22
Q3 2010 $1.04B Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-26
Q2 2010 $1.06B Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-27
Q1 2010 $1.29B Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.